Acorda Therapeutics Statistics
Total Valuation
ACORQ has a market cap or net worth of $12,421. The enterprise value is $186.57 million.
| Market Cap | 12,421 |
| Enterprise Value | 186.57M |
Important Dates
The last earnings date was Tuesday, August 20, 2024.
| Earnings Date | Aug 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACORQ has 1.24 million shares outstanding. The number of shares has increased by 7.45% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.24M |
| Shares Change (YoY) | +7.45% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.61 |
| EV / EBITDA | 338.61 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | 85.85 |
| Debt / FCF | n/a |
| Interest Coverage | -0.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.60% |
| Return on Capital (ROIC) | -11.39% |
| Revenue Per Employee | $1.13M |
| Profits Per Employee | -$2.58M |
| Employee Count | 102 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.48 |
Taxes
| Income Tax | -41.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.94% in the last 52 weeks. The beta is 1.69, so ACORQ's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | -99.94% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 6.90 |
| Relative Strength Index (RSI) | 32.30 |
| Average Volume (20 Days) | 16,166 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ACORQ had revenue of $115.66 million and -$263.43 million in losses. Loss per share was -$212.10.
| Revenue | 115.66M |
| Gross Profit | 95.19M |
| Operating Income | -24.08M |
| Pretax Income | -304.44M |
| Net Income | -263.43M |
| EBITDA | 551,000 |
| EBIT | -24.08M |
| Loss Per Share | -$212.10 |
Balance Sheet
The company has $9.36 million in cash and $195.92 million in debt, giving a net cash position of -$186.56 million or -$150.19 per share.
| Cash & Cash Equivalents | 9.36M |
| Total Debt | 195.92M |
| Net Cash | -186.56M |
| Net Cash Per Share | -$150.19 |
| Equity (Book Value) | -185.77M |
| Book Value Per Share | -149.56 |
| Working Capital | -175.48M |
Cash Flow
In the last 12 months, operating cash flow was -$27.15 million and capital expenditures -$264,000, giving a free cash flow of -$27.42 million.
| Operating Cash Flow | -27.15M |
| Capital Expenditures | -264,000 |
| Free Cash Flow | -27.42M |
| FCF Per Share | -$22.07 |
Margins
Gross margin is 82.30%, with operating and profit margins of -20.82% and -227.75%.
| Gross Margin | 82.30% |
| Operating Margin | -20.82% |
| Pretax Margin | -263.21% |
| Profit Margin | -227.75% |
| EBITDA Margin | 0.48% |
| EBIT Margin | -20.82% |
| FCF Margin | -23.70% |
Dividends & Yields
ACORQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.45% |
| Shareholder Yield | -7.45% |
| Earnings Yield | -1,570,968.07% |
| FCF Yield | -163,492.80% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 5, 2023. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Jun 5, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
ACORQ has an Altman Z-Score of -22.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.98 |
| Piotroski F-Score | 3 |